Mandatory Credit: Photo by Geoff Moore/REX/Shutterstock (845757c)
An Avery Dennison blood transfusion scanner
An Avery Dennison blood transfusion scanner being used in a trial at a hospital in the West Country, Britain - 29 Jan 2009
Avery Dennison blood transfusion scanner being used in a trial at a hospital in the West Country. The system checks to see that the right blood type is given to the right patient it can also tell if a blood pack has been out of from the blood storage fridge for longer than allowed. The older form of written records could mis-read allowing mistakes, this new system ensures 100 percent accuracy.Geoff Moore—REX/Shutterstock
- Previous Rank427
- Revenues ($M)7159.0
- Revenue Percent Change8.2
- Profits ($M)467.4
- Profits Percent Change65.9
- Assets ($M)5177.5
- Employees30000
The label-maker, headquartered in Glendale, Calif., has about 30,000 employees in more than 50 countries.
Company Info
| CEO | Mitchell R. Butier |
| CEO Title | President, Chief Executive Officer & Director |
| Sector | Materials |
| Industry | Packaging, Containers |
| HQ Location | Glendale, Calif. |
| Website | www.averydennison.com |
| Years on Fortune 500 List | 45 |
| Employees | 30,000 |
Key Financials (Last Fiscal Year)
| Revenues ($M) | $7,159 |
| Profits ($M) | $467.4 |
| Assets ($M) | $5,177.5 |
| Total Stockholder Equity ($M) | $955.1 |
Profit Ratios
| Profit as % of Revenues | 6.5% |
| Profits as % of Assets | 9.0% |
| Profits as % of Stockholder Equity | 48.9% |
Earnings Per Share (Last Fiscal Year)
| Earnings Per Share ($) | 5.28 |
| EPS % Change (from 2017) | 68.7% |
| EPS % Change (5 year annual rate) | 19.6% |
| EPS % Change (10 year annual rate) | 6.9% |
Total Return
| Total Return to Investors (2018) | -20.2% |
| Total Return to Investors (5 year, annualized) | 14.9% |
| Total Return to Investors (10 year, annualized) | 13.7% |